Can you save more lives by using alternate therapeutic sequencing for patients with HFrEF?

A recent analysis suggests an innovative approach to treatment sequencing with an SGLT2i may lead to optimal outcomes.1

Therapeutic guidelines are clear on which therapies to prescribe for your patients with HFrEF2.3; now, a recent modelling analysis offers insight on when to start those therapies for optimal outcomes.1 A new video explores the potential benefits of several sequencing strategies, with supporting data modelled from six key clinical trials of patients with HF.

Optimal sequencing of HFrEF treatments

Reference:

  1. Shen L et al. Eur Heart J. 2022;43(27):2573-2587.
  2. Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599-3726.
  3. Heidenreich PA et al. J Am Coll Cardiol. 2022;79(17):e263-e421.

Watch more from AZ Healthcare Pro

Back to top